• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

    2.660 +0.050 (+1.92%)
    Streaming Delayed Price Updated: 10:06 AM EDT, Jun 18, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 103,771
    Open 2.630
    Bid (Size) 2.660 (1,600)
    Ask (Size) 2.670 (1,800)
    Prev. Close 2.610
    Today's Range 2.630 - 2.680
    52wk Range 1.770 - 5.810
    Shares Outstanding 412,429,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Q1 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks
    As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology industry, includ... 
    Via StockStory
    News headline image
    1 Stock Under $10 to Target This Week and 2 We Find Risky
    Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying busi... 
    Via StockStory

    Performance

    YTD
    -3.3%
    -3.3%
    1 Month
    +6.4%
    +6.4%
    3 Month
    +22.6%
    +22.6%
    6 Month
    -4.3%
    -4.3%
    1 Year
    -39.4%
    -39.4%

    More News

    Read More
    News headline image
    1 Small-Cap Stock with Competitive Advantages and 2 We Ignore
    Via StockStory
    News headline image
    GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs
    From GoodRx
    Via Business Wire
    News headline image
    3 Value Stocks That Fall Short
    Via StockStory
    News headline image
    GoodRx, RadNet, Addus HomeCare, Novavax, and Mettler-Toledo Shares Plummet, What You Need To Know
    Via StockStory
    Topics Economy
    News headline image
    The 5 Most Interesting Analyst Questions From GoodRx’s Q1 Earnings Call
    Via StockStory
    Topics Earnings
    News headline image
    GoodRx vs. Hims & Hers Health: Stagnation vs. Growth in Revenue ↗
    Via The Motley Fool
    News headline image
    GoodRx (GDRX) Q1 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    1 Mooning Stock on Our Buy List and 2 We Question
    Via StockStory
    News headline image
    GoodRx (GDRX) Stock Trades Up, Here Is Why
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    GoodRx (NASDAQ:GDRX) Beats Q1 CY2026 Sales Expectations
    Via StockStory
    News headline image
    GoodRx Reports First Quarter 2026 Results
    From GoodRx Holdings, Inc.
    Via Business Wire
    News headline image
    GoodRx (GDRX) Reports Earnings Tomorrow: What To Expect
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Why GoodRx (GDRX) Stock Is Trading Up Today
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients
    From GoodRx
    Via Business Wire
    News headline image
    Healthcare Technology Stocks Q4 Recap: Benchmarking GoodRx (NASDAQ:GDRX)
    Via StockStory
    News headline image
    1 Cash-Producing Stock with Exciting Potential and 2 We Ignore
    Via StockStory
    News headline image
    GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call
    From GoodRx Holdings, Inc.
    Via Business Wire
    News headline image
    3 Reasons GDRX is Risky and 1 Stock to Buy Instead
    Via StockStory
    Topics Supply Chain
    News headline image
    Why GoodRx (GDRX) Stock Is Up Today
    Via StockStory
    News headline image
    GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price
    From GoodRx
    Via Business Wire
    News headline image
    GoodRx Expands Access to Eli Lilly and Company’s New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide
    From GoodRx
    Via Business Wire
    News headline image
    1 Healthcare Stock on Our Watchlist and 2 We Avoid
    Via StockStory
    News headline image
    1 Value Stock with Exciting Potential and 2 Facing Challenges
    Via StockStory

    Frequently Asked Questions

    Is GoodRx Holdings, Inc. - Class A Common Stock publicly traded?
    Yes, GoodRx Holdings, Inc. - Class A Common Stock is publicly traded.
    What exchange does GoodRx Holdings, Inc. - Class A Common Stock trade on?
    GoodRx Holdings, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for GoodRx Holdings, Inc. - Class A Common Stock?
    The ticker symbol for GoodRx Holdings, Inc. - Class A Common Stock is GDRX on the Nasdaq Stock Market
    What is the current price of GoodRx Holdings, Inc. - Class A Common Stock?
    The current price of GoodRx Holdings, Inc. - Class A Common Stock is 2.660
    When was GoodRx Holdings, Inc. - Class A Common Stock last traded?
    The last trade of GoodRx Holdings, Inc. - Class A Common Stock was at 06/18/26 10:06 AM ET
    What is the market capitalization of GoodRx Holdings, Inc. - Class A Common Stock?
    The market capitalization of GoodRx Holdings, Inc. - Class A Common Stock is 1.10B
    How many shares of GoodRx Holdings, Inc. - Class A Common Stock are outstanding?
    GoodRx Holdings, Inc. - Class A Common Stock has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.